AK132 is a bispecific antibody developed by Akeso, targeting the recombinant humanized Claudin18.2 (CLDN18.2) splice variant 2 and CD47 for the treatment of various cancers, including gastric, ...

A team led by Prof. Wang Chao and Prof. Huang Chengdong from the University of Science and Technology of China (USTC) of the ...

Melissa Nieves, LND, RD, is a registered dietitian with Practical Nutrition, LLC. She also works as a bilingual telehealth dietitian for Vida Health Program. Rich Scherr is an updates strategist ...

Grilled cheese, chicken and turkey rule the sandwich category, according to a recent survey. The poll of 2,000 general ...

GRAND JUNCTION, Colo. (KREX) – 15-year-old Grand Junction High ... So the FDA has jurisdiction over produce, whereas USDA has ...

The food at Spitz is as vibrantly colored as the interior — pink pickled onions, pops of green from cilantro or diced peppers ...

The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

MONDAY, Oct. 21, 2024 (HealthDay News) -- Teenagers are increasingly turning to protein-packed bars, shakes and powders to help them add muscle to their frames, a new study shows. Two in five ...

Takahashi’s team has previously discovered a new protein complex within the synaptic junction, called TrkC-PTPσ, which is only found in excitatory synapses. The genes coding for TrkC (NTRK3) and PTPσ ...

CRP (C-reactive protein) is a prototypical acute phase reactant. Upon dissociation of the pentameric isoform (pCRP [pentameric CRP]) into its monomeric subunits (mCRP [monomeric CRP]), it exhibits ...

Claudin-6 (CLDN6) is a tight junction protein that has been found to be up-regulated in around 20 different types of cancer, among them ovarian, endometrial and germ cell tumors. Conventional T-cell ...